The global anti-obesity devices, expected to grow at a significant CAGR due to increase in the prevalence of obesity. According to WHO, obesity has doubled since 2015. In 2014 around 13% of adults aged 18 years or above were obese, and cause of death of approximately 2.8 Mn people annually around the globe. Rising demand for less invasive procedures for obesity treatment has significantly affected the growth of anti-obesity devices market. Similarly, increase in disposable income in developing countries, and recent product approvals from U.S. Food and Drug Administration for new anti-obesity devices are the major factors boosting the growth of anti-obesity devices market. However, the side effects associated with the use of these devices, availability of medications for obesity, and product failure in some cases might hamper the growth of anti-obesity devices market over the forecast period.A sample of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-anti-obesity-devices-market/#ulp-4H8Z4LpNMLEuOnnx[/URL]
Anti-obesity treatment market segmented on the basis of product type, method of deployment, and end user
Based on product-type, anti-obesity devices market has been segmented into the following:
Gastric bands
Electrical stimulation system
Gastric balloon system
Gastric emptying system
Appetite suppressors
Based on the method of deployment, anti-obesity devices market has been segmented into the following:
Trans-oral
Endoscopy
Surgery
Based on the end user, anti-obesity devices market has been segmented into the following:
Hospitals
Gastroenterology clinics
Ambulatory surgical centers
To view TOC of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-anti-obesity-devices-market/#ulp-c654SbFYO64MsOhu[/URL]
Global anti-obesity devices market is in the nascent stage with local, and international players operating in the anti-obesity devices market. Conventionally, anti-obesity devices are expected to dominate in the obesity treatment market due to the ease of administration and lesser cost, and minimal invasiveness. FDA has approved the various types of anti-obesity devices, which may affect the growth of anti-obesity devices market positively. For instance, In January 2015, FDA has approved the EnteroMedics Inc.’s Vbloc Maestro system intended to treat morbid obesity. Similarly, in February 2011, Allergan got approval for anti-obesity device Lap-band, the adjustable gastric band used in the treatment of obesity. With an increasing number of device approvals, the anti-obesity market is anticipated to have a positive outlook in the forecast period.
Need more information about this report @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-anti-obesity-devices-market/#ulp-14mlyhjMGhVjZqa3[/URL]
Some of the players in anti-obesity devices market are Allergan, Inc. (U.S.), Medtronic. (Covidien PLC) (U.S.), EnteroMedics, Inc (U.S.), Cousin Biotech (France), Surgical IOC (Peters Surgical SAS) (France), PARE Surgical Inc. (U.S.), and GI Dynamics (U.S.) to name a few.
"Precision Business Insights,
Email: sales@precisionbusinessinsights.com
Toll Free(US): +1-866-598-1553"